Citius Oncology, Inc. (CTOR) Dividend History

Citius Oncology, Inc. (CTOR) is a biopharmaceutical company focused on developing targeted cancer therapies. The company aims to advance innovative treatments by leveraging immunology and oncology research to improve outcomes for cancer patients.

420 Lexington Ave,, New York, NY, 10017
Phone: (347) 627-0058

Dividend History

Citius Oncology, Inc. currently does not pay dividends

Company News

Citius Oncology Announces Pricing of $9.0 Million Public Offering

Citius Oncology priced a public offering of 6,818,182 shares and warrants at $1.32 per share, expecting to raise approximately $9.0 million to support LYMPHIR commercialization and general corporate purposes.

Benzinga

Featured Companies: CTXR

Page data last updated 07/23/2025 17:07:24 UTC